Royal Prima PT Cash Flow Conversion Efficiency

Latest as of September 2025: 0.002x

Royal Prima PT cash flow conversion efficiency. Based on the latest financial reports, Royal Prima PT (PRIM) has a cash flow conversion efficiency ratio of 0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp1.86 Billion ≈ $108.71K USD) by net assets (Rp955.60 Billion ≈ $55.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Royal Prima PT (2014–2024)

Cash flow conversion efficiency of Royal Prima PT from 2014 to 2024. This chart illustrates how Royal Prima PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. View PRIM stock price and chart for real-time trading data and today's change.

Royal Prima PT Cash Flow Conversion Ratio Explained

Royal Prima PT cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Royal Prima PT Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Royal Prima PT ranked by their cash flow conversion efficiency. Also see PRIM market cap overview for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Plaza Wires Limited
NSE:PLAZACABLE
-0.026x
MIRA Pharmaceuticals, Inc. Common Stock
NASDAQ:MIRA
-0.148x
A SPAC III Acquisition Corp. Class A Ordinary Shares
NASDAQ:ASPC
-0.056x
PLB Engineering Bhd
KLSE:7055
-0.033x
Promise Technology Inc
TW:3057
-0.066x
Conduril - Engenharia S.A
LS:CDU
N/A
Eutilex.Co.Ltd
KQ:263050
-0.083x
Higgstec
TWO:5220
0.008x

Annual Cash Flow Conversion Efficiency for Royal Prima PT (2014–2024)

The table below shows the annual cash flow conversion efficiency of Royal Prima PT from 2014 to 2024. Review PRIM free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Rp962.38 Billion
≈ $56.39 Million
Rp46.98 Billion
≈ $2.75 Million
0.049x +125.21%
2023-12-31 Rp981.10 Billion
≈ $57.49 Million
Rp21.27 Billion
≈ $1.25 Million
0.022x -1.33%
2022-12-31 Rp982.66 Billion
≈ $57.58 Million
Rp21.59 Billion
≈ $1.27 Million
0.022x -90.97%
2021-12-31 Rp964.21 Billion
≈ $56.50 Million
Rp234.54 Billion
≈ $13.74 Million
0.243x +259.56%
2020-12-31 Rp889.35 Billion
≈ $52.11 Million
Rp60.16 Billion
≈ $3.53 Million
0.068x +1830.15%
2019-12-31 Rp851.17 Billion
≈ $49.88 Million
Rp2.98 Billion
≈ $174.81K
0.004x -91.58%
2018-12-31 Rp848.87 Billion
≈ $49.74 Million
Rp35.33 Billion
≈ $2.07 Million
0.042x -53.08%
2017-12-31 Rp250.42 Billion
≈ $14.67 Million
Rp22.22 Billion
≈ $1.30 Million
0.089x -96.16%
2016-12-31 Rp12.13 Billion
≈ $710.64K
Rp28.02 Billion
≈ $1.64 Million
2.310x +135.31%
2015-12-31 Rp722.89 Million
≈ $42.36K
Rp-4.73 Billion
≈ $-277.14K
-6.543x -274.24%
2014-12-31 Rp-2.10 Billion
≈ $-123.29K
Rp3.68 Billion
≈ $215.54K
-1.748x --

About Royal Prima PT

JK:PRIM Indonesia Medical Care Facilities
Market Cap
$23.95 Million
Rp408.78 Billion IDR
Market Cap Rank
#24338 Global
#488 in Indonesia
Share Price
Rp121.00
Change (1 day)
-0.82%
52-Week Range
Rp68.00 - Rp133.00
All Time High
Rp1640.00
About

PT Royal Prima Tbk engages in providing hospital services in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. It provides health services, such as emergency, outpatient, inpatient, laboratorium, radiology, medical rehab, pharmacy, and MCU; and general surgery, internist, VCT, ICU, cardiology, urology, haemodialysis, m… Read more